Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review

Lung cancer (LC) accounts for the largest number of tumor-related deaths worldwide. As the overall 5-year survival rate of LC is associated with its stages at detection, development of a cost-effective and noninvasive cancer screening method is necessary. We conducted a systematic review to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bin, Li, Xiaoyan, Ren, Tianyi, Yin, Yiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683200/
https://www.ncbi.nlm.nih.gov/pubmed/31396403
http://dx.doi.org/10.1038/s41420-019-0207-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683200/
https://www.ncbi.nlm.nih.gov/pubmed/31396403
http://dx.doi.org/10.1038/s41420-019-0207-1

Ejemplares similares